| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $103.4M | +11.3% |
| SG&A Expense | $28.9M | -5.8% |
| Operating Income | -$132.3M | -7.1% |
| Net Income | -$121.8M | -5.5% |
| EPS (Basic) | -$2.02 | +17.2% |
| EPS (Diluted) | -$2.02 | +17.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $25.3M | -17.4% |
| Short-term Investments | $207.6M | +21.3% |
| Current Assets | $235.6M | +15.3% |
| Total Assets | $277.7M | +25.9% |
| Current Liabilities | $21.8M | +0.6% |
| Total Liabilities | $40.6M | +61.9% |
| Stockholders' Equity | $237.1M | +21.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$107.1M | -27.9% |
| Capital Expenditures | $3.5M | +16.4% |
| Investing Cash Flow | -$34.6M | -142.4% |
| Financing Cash Flow | $136.4M | — |
| Free Cash Flow | -$110.6M | -27.5% |